Gibbs Wealth Management Raises Stake in Tenet Healthcare Corporation $THC

Gibbs Wealth Management grew its holdings in Tenet Healthcare Corporation (NYSE:THC) by 81.6% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 6,472 shares of the company’s stock after buying an additional 2,908 shares during the period. Gibbs Wealth Management’s holdings in Tenet Healthcare were worth $1,221,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Alamar Capital Management LLC purchased a new stake in Tenet Healthcare during the 1st quarter valued at approximately $2,097,000. Lido Advisors LLC purchased a new position in shares of Tenet Healthcare in the 1st quarter valued at approximately $427,000. First Trust Advisors LP increased its holdings in shares of Tenet Healthcare by 11.8% in the first quarter. First Trust Advisors LP now owns 240,019 shares of the company’s stock valued at $45,294,000 after purchasing an additional 25,263 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Tenet Healthcare by 10.5% during the first quarter. PNC Financial Services Group Inc. now owns 6,086 shares of the company’s stock worth $1,148,000 after purchasing an additional 580 shares during the last quarter. Finally, Parallel Advisors LLC grew its position in Tenet Healthcare by 108.9% in the 1st quarter. Parallel Advisors LLC now owns 1,389 shares of the company’s stock valued at $262,000 after buying an additional 724 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

THC has been the subject of a number of analyst reports. Robert W. Baird cut their price objective on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research report on Tuesday, May 5th. Wells Fargo & Company boosted their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. TD Cowen cut their price target on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating for the company in a report on Monday, June 22nd. KeyCorp lowered their price objective on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Royal Bank Of Canada cut their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research note on Friday, May 1st. Seventeen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $244.84.

Insider Buying and Selling

In related news, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by corporate insiders.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $199.85 on Friday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The firm’s 50-day simple moving average is $184.43 and its 200 day simple moving average is $197.37. Tenet Healthcare Corporation has a 52 week low of $146.60 and a 52 week high of $247.21. The firm has a market capitalization of $17.22 billion, a PE ratio of 10.39, a P/E/G ratio of 1.62 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Friday, July 24th. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The company had revenue of $5.63 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.02 earnings per share. On average, equities research analysts predict that Tenet Healthcare Corporation will post 17.5 EPS for the current fiscal year.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported second-quarter EPS of $6.12, well above consensus, and revenue of $5.63 billion, also topping estimates, signaling stronger-than-expected operating performance. Article Title
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above Wall Street expectations, which suggests management sees continued earnings strength ahead. Article Title
• Positive Sentiment: Investor optimism was also supported by Tenet’s improving credit profile and recent analyst sentiment, which had already set up the stock for a strong move into earnings. Article Title
• Neutral Sentiment: Analysts continue to view the stock favorably overall, with a consensus “Moderate Buy” rating, though some recent commentary has been more cautious on valuation. Article Title

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.